Korean Circ J.  2008 May;38(5):257-263. 10.4070/kcj.2008.38.5.257.

redictors of Hospital Mortality for Patients With Acute Myocardial Infarction That was Treated With an Artificial Ventilator and/or an Intra-aortic Balloon Pump

• Kim JY
• Jeong MH
• Cho JH
• Hong YJ
• Kim JH
• Ahn YK
• Kang JC

• KMID: 2225787
• DOI: http://doi.org/10.4070/kcj.2008.38.5.257

Abstract

BACKGROUND AND OBJECTIVES: The mortality rate of complicated acute myocardial infarction (AMI) patients who require an artificial ventilator and/or an intra-aortic balloon pump (IABP) at a coronary care unit (CCU) has been reported to be very high. The aims of this study were to evaluate the mortality rate and to investigate the predictors of hospital death for these critically ill patients.
SUBJECTS AND METHODS
We retrospectively analyzed a total of 134 complicated AMI patients who were treated with an artificial ventilator and/or an IABP at the CCU of Chonnam National University Hospital between January 2004 and December 2005. We compared the clinical characteristics, the laboratory, echocardiographic and coronary angiographic findings and the Global Registry of Acute Coronary Event (GRACE) score between the survivors and non-survivors.
RESULTS
The overall mortality rate was 56.0%. The following variables were more common in non-survivors: smoking and a history of coronary artery bypass grafting, the incidence of cardiogenic shock and the use of an IABP and/or percutaneous coronary intervention (PCI). The non-survivors had higher levels of high sensitivity C-reactive protein (hs-CRP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) and a higher GRACE score (p<0.05, respectively). The predictive factors for hospital mortality according to multiple logistic regression analysis were the use of an IABP (odds ratio: 3.52, 95% CI: 1.182-11.541), PCI (odds ratio: 0.29, 95% CI: 0.057-0.843) and a high GRACE score (odds ratio: 1.03, 95% CI: 1.015-1.041).
CONCLUSION
The predictive factors for hospital death for patients with AMI and who were treated by an IABP and/or an artificial ventilator were the use of IABP and PCI and a high GRACE score.

Keyword

Myocardial infarction; Ventilators; Intra-aortic balloon pumping

MeSH Terms

C-Reactive Protein
Coronary Artery Bypass
Coronary Care Units
Critical Illness
Hospital Mortality
Humans
Incidence
Intra-Aortic Balloon Pumping
Logistic Models
Myocardial Infarction
Percutaneous Coronary Intervention
Retrospective Studies
Shock, Cardiogenic
Smoke
Smoking
Survivors
Ventilators, Mechanical
C-Reactive Protein
Smoke

Reference

1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988. 41:155–178.

2. Rotstein Z, Mandelzweig L, Lavi B, Eldar M, Gottlieb S, Hod H. Does the coronary care unit improve prognosis of patients with acute myocardial infarction?: a thrombolytic era study. Eur Heart J. 1999. 20:813–818.

3. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Ali A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J. 1996. 131:250–256.

4. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 2000. 343:385–391.

5. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 2001. 344:1895–1903.

6. Kuch B, Bolte HD, Hoermann A, Meisinger C, Loewel H. What is the real hospital mortality from acute myocardial infarction?: epidemiological vs, clinical view. Eur Heart J. 2002. 23:714–720.

7. Shin ES, Jeong MH, Kim KH, et al. The predictive factor of mortality and prognosis of cardiovascular patients admitted at coronary care unit. Korean J Med. 2006. 70:386–392.

8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg. 1985. 202:685–693.

9. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985. 312:932–936.

10. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003. 163:2345–2353.

11. Pena-Gil C, Figueras J, Soler-Soler J. Acute cardiogenic pulmonary edema: relevance of multivessel disease, conduction abnormalities and silent ischemia. Int J Cardiol. 2005. 103:59–66.

12. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999. 340:1162–1168.

13. Lesage A, Ramakers M, Daubin C, et al. Complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in a series of 157 patients. Crit Care Med. 2004. 32:100–105.

14. Ahn MS, Yoo BS, Kim JY, et al. Predictive factors of survival for intra-aortic balloon pump in acute myocardial infarction treated with angioplasty. Korean Circ J. 2003. 33:22–29.

15. Iakobishvili Z, Behar S, Boyko V, Battler A, Hasdai D. Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines? Am Heart J. 2005. 149:98–103.

16. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999. 341:625–634.

17. van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003. 24:28–66.

18. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002. 23:1809–1840.

19. Lim SY, Jeong MH, Bae EH, et al. Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. Circ J. 2005. 69:154–158.

20. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2000. 36:Suppl A. 1123–1129.

21. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000. 36:2056–2063.

22. Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction. Lancet. 2001. 358:1571–1575.

23. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000. 343:1139–1147.

24. Lee GS, Lee CS, Choi HJ, et al. Clinical utility of APACHE III scoring system as a method for predicting the patient with cardiovascular disease admitted in coronary care unit (CCU). Korean Circ J. 2000. 30:1024–1034.

25. Shin ES, Jeong MH, Lee YH, et al. Clinical value of GRACE score in the prediction of mortality in patients with acute coronary syndrome. Korean J Crit Care Med. 2006. 21:101–108.

26. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998. 339:321–328.

27. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001. 344:1879–1887.

28. Cha BS, Kim HJ. Metabolic syndrome and cardiovascular disease. Korean Circ J. 2003. 33:645–652.

29. Zeller M, Steg PG, Rabisy J, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005. 165:1192–1198.

30. Birhan Yilmaz M, Guray U, Guray Y, et al. Metabolic syndrome is associated with extension of coronary artery disease in patients with ST-segment elevation acute coronary syndromes. Coron Artery Dis. 2005. 16:287–292.